Proteomics in Drug Discovery

• 발행기관: 대한약학회
• 저자명: W. Rodney M athews
• 간행물 정보: 『추계총회 및 학술대회』(2002년) vol.2, 73~73쪽, 전체 0쪽
• 주제분류: 의약학 > 내과학
• 파일형태: PDF
• 발행일자: 2002.10.30

영문 초록

The study of the protein complement of the genome, or proteome, represents an important new avenue for drug discovery. Proteomics research aims to quantify and characterize all of the expressed proteins in a biological system, and to determine the effect of various perturbations of the system on the expressed proteins. The resulting protein expression data can then used to help discover and characterize new drug targets, evaluate the mechanism of action of lead compounds, and investigate potential toxicity of novel therapeutic agents. A critical aspect of proteomics is protein identification. Mass spectrometry enables rapid identification and characterization of expressed proteins and bridges the gap between genome and proteome. A flexible, high performance protein identification system based on commercially available instrumentation has been assembled and implemented. The performance of the system, including validation with protein standards and its application to real world problems in drug discovery will be described.